CDC advisory committee greenlights booster for certain groups

After FDA authorization last night, the CDC advisory committee approved a third dose of Pfizer’s Covid vaccine for those 65 and older, long-term care facility residents, and people ages 50 to 64 with underlying medical conditions.Sept. 23, 2021